This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
Attend Our Hybrid Event on 5-8 December 2022!
Beurs van BerlageAmsterdam

Attend Our Hybrid Event on 5-8 December 2022!
Beurs van Berlage,
Amsterdam

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest analytical techniques & vector technologies to revolutionise your cell, gene & gene edited ex vivo cell therapy programs

Early Confirmed Speaker List for CGT Europe 2022 Released!

Get a sneak peek of the list of early confirmed speakers for Informa's Cell and Gene Therapy Manufacturing & Commercialisation Europe event delivered as a hybrid event on 5-8 December 2022 in Amsterdam, Netherlands.

Returning as an in person event for the first time since 2019, this event brings together 400+ world renowned cell & gene leaders and will feature the latest technologies, manufacturing, analytical  and supply chain strategies to revolutionise your clinical and late stage programs.

BRINGING YOU CUTTING EDGE CASE STUDIES TO IMPROVE EFFICIENCIES IN CELL & GENE THERAPY PRODUCTION

Cell Therapy

  • Discover process optimisation and implementation strategies for automated, closed and integrated systems in cell therapy manufacturing
  • Build your analytical toolbox to improve testing, characterisation & validation strategies
  • Get to grips with raw materials, cryopreservation, and logistical requirements for seamless end to end supply chains

Gene Edited Ex Vivo Cell Therapy

  • Build a strategy for the scale up and manufacturing of for next generation “off the shelf” allogeneic and gene edited modalities
  • Get to grips with manufacturing and commercialisation strategies for CAR-Ts, NK cells, TCRs, TILs and iPSCs products
  • Beyond rare diseases: Overcome the challenges of expanding to larger patient populations with cell and gene therapies

In Vivo Gene Therapy

  • Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing
  • Discuss next generation non-viral gene editing techniques and their potential to transform the field
  • Develop analytical toolkits for AAV characterisation, validation and understanding CQAs

CONNECT WITH KEY BUYERS AT CELL & GENE THERAPY EUROPE 2022

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247